Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

Article of the Week

Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies

ARTICLE: Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies AUTHORS: Steven G Coca, George Vasquez-Rios, Sherry… Read More »Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies

Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

 ARTICLE: Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants AUTHORS: Emily J Fray, Fengting Wu, Francesco R Simonetti, Carolin Zitzmann, Narmada Sambaturu, Carmen Molina-Paris, Alexandra… Read More »Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

ARTICLE: Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia AUTHORS: Jennifer A White, Fengting Wu, Saif Yasin, Milica Moskovljevic, Joseph Varriale, Filippo Dragoni, Angelica Camilo-Contreras, Jiayi… Read More »Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

ARTICLE: Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus AUTHORS: Thomas Dörner, Yoshiya Tanaka, Ernst… Read More »Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus